8:35 AM ET
8-K
Leadership Change
MetaVia Leadership Change
MetaVia Inc. appointed Sarah Kaplan Browne, M.D. as Chief Medical Officer, effective October 12, 2026. Dr. Browne brings over 20 years of experience in clinical development and regulatory science, specifically in liver and metabolic diseases like MASH. She will lead the clinical strategy for the company's cardiometabolic pipeline, including DA-1726 and vanoglipel.